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INTRAVASCULAR haemolysis may occur in malignant neoplastic diseases and
is sometimes responsible for anaemia observed in these patients (Stats, Rosenthal
and Wasserman, 1947; Hyman, 1954). This observation led us to study the
haemolytic activity ofplasma ofpatientswithmalignant tumours. Thepreliminary
results indicate that although frank haemolysis does not result fromincubation of
normal erythrocytes with the plasma of these patients, the mean corpuscular
volume (MCV) of the incubated red cells is usually increased significantly. No
such effect was obtained with plasma of normal individuals, or of patients with
benign tumours.
MATERIAL
(1) Control series
(a) Normal controls.-The plasma of 28 men and women from 25 to 55 years
of age was studied. All of these healthy subjects were members of the hospital
staff with normal blood count, urinalysis, blood pressure, X-ray of the chest and
no gross abnormalities on physical examination.
(b) Patients with benign tumours.-This series consisted of 8 patients with
the following histologically confirmed benign tumours: Fibro-adenoma of the
breast, 1 case; hydatidiform mole, 2 cases; myoma of the uterus, 2 cases;
papilloma of the bladder, 1 case; serous cystadenoma of the ovary, 2 cases.
(2) Patients with malignant tumours
This series consisted of 15 patients suffering from the following malignant
tumours: adenocarcinoma of the breast, 3 cases; granulosa cell carcinoma of
the ovary, 2 cases; and 1 case each of: squamous cell carcinoma of the uterine
cervix, squamous cell carcinoma ofthe penis, adenocarcinoma ofthe endometrium,
adenocarcinoma of the ovary, sarcoma of the uterus, serous cystadenocarcinoma
of the ovary, papillary transitional carcinoma of the bladder, adenocarcinoma
of the colon, generalized carcinomatosis of the peritoneum and mucoid carcinoma
of the lung.
METHOD
Blood samples of 10 ml. were taken from the cubital vein and added to 0 05
ml. of a solution of sodium heparin containing 1000 Toronto units per ml. The
MCV of erythrocytes was determined from the red cell count and haematocrit
reading. TheerythrocytescountswereaveragedintwoSpencercounting chambers.Y. M. BROMBERG AND M. B. ERDREICH
The haematocrit was determined in Wintrobe tubes centrifuged for 45 minutes
at 3000 r.p.m. in an international centrifuge.
The erythrocytes were separated from the plasma in a specially constructed
siliconized centrifuge tube with a constricted portion, to facilitate accurate filling
to the 4 ml. mark (Fig. 1). After being filled with blood, the tube was centrifuged
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FiG. I.-Special tube used in inicubating blood phases. Overall length 90 mm. Constricted
portion allows for accurate filling to 4*0 ml. mark.
at 1500 r.p.m. for 5 minutes. The plasma was then removed and the plasma of
another subject of the same blood group added, to bring the total volume again
to the 4 ml. mark. The erythrocytes were then resuspended by repeated gentle
inversion and the system incubated at 370 C., for one hour. The tube was then
again repeatedly inverted and a sample taken for determining the haematocrit.
The MCV after incubation was determined by relating this second haematocrit
reading to the initial count. Thus repeated erythrocytes counts which might
introduce a high degree of error, were obviated.
RESULTS
Neither normal plasma, nor the plasma of patients with benign tumours
modified the MCV of normal erythrocytes (Tables I and II). Conversely, normal
plasma had no effect on the erythrocytes of patients with benign tumours (Table
Ill).
On the other hand, the plasma of 11 out of 15 patients with malignant tumours
significantly increased the MCV of normal erythrocytes (Table IV).
The degree of erythrocytes enlargement did not depend on the extension of
the malignant disease, nor the degree of deterioration of the patient's general
condition. In fact, the greatest increase in MCV of normal erythrocytes was
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produced by the plasma of patients with squamous cell carcinoma of the cervix
and squamous cell carcinoma of the penis without evidence of metastases and in
fair general condition (Table IV, case 1, 2). On the other hand, no change in the
MCV of normal erythrocytes occurred in the plasma of a patient in the terminal
stage ofadenocarcinoma ofthe colon (Table IV, case 14).
TABLE I.-The Effect ofNormal Plasma on the Mean Corpuscular Volume (MCV)
of Erythrocytes of Other Normal Persons in Incubated Systems
- ~~~~~~~~~~~~~c~ase
1 2 3
MCV before incuba- 78 25 95 18 86 31
tion
MCV after incuba- 78404 96A40 86 31
tion
Difference
4 5 6 7 8 9
85*00 85*71 88*42 86*91 79*79 87 77
10
90o00
85*00 86*73 89.48 85*93 80 80 88*88 90 00
-0*19 +1b22 0.00 0-00 +1402 +106 -0*92 +1401 +1<11 0 00
Case
le -A -
11 12 13
MCV before incuba- 80 00 90 22 78 90
tion
MCV after incuba- 78 94 90 22 81a88
tion
Difference
14 15 16 17 18 19
83*87 83*14 89*91 92*68 86*00 85*99
20
89 37
84*95 83*14 88*10 90*24 85 00 88.11 89*37
. -1*06 0.00 +2 98 +1-08 0.00 -1.81 -2-44 -1.00 +2112 0.00
Case
21 22 23 24 25 26 27 28
MCV before incuba- 88*42 83*67 91*11 94 30 82-37 80491 83 51 89-28
tion
MCV after incuba- 88*42 82*66 91' 11 94
-30 82-37 78484 83 51 88d17
tion
Difference . . 0.00 -1.01 0 00 0 00 0400 -2107 0400 -1>09
Mean ofdifference was -0 82;
Standard deviation was ±0 84;
Standard error was ±0
- 16.
TABLE II.-The Effect of P?asma of Patients with Benign Tumours on the Mean
Corpuscular Volume (MCV) ofErythrocytes ofControls in Incubated Systems
Case
1
2
3
4
5
6
7
8
Age
72
46
25
27
53
49
53
38
MCV*
Histological before
diagnosis incubation
Papilloma of the bladder 86v46
Fibro-adenoma of the breast 82 99
Hydatidiform mole . 89-48
,, ,, 85 50
Myoma of the uterus . 91-00
,, ,, ,, PI, 86-04
Serous cystadenoma of the ovary . 95 55
11, ,, II J,,I 11 80-51
MCVt
after
incubation
88*54
82 99
89*48
86 00
90 00
86*04
95.55
80-51
Difference
+2-08
0*00
0*00
+0*50
-1*00
0*00
0*00
0*00
*t The difference between the two means was 0, 2;
The standard error was 1 1.
Thelevel ofsignificance (" T Test ") as related to the normal controls series was 0,2 (not significant).766 Y. M. BROMBERG AND M. B. ERDREICH
TABLE III.-The Effect of Plsma of Control Persons on the Mean Corpuscular
Volume (MCV) ofErythrocytes of Patients with Benign Tumours in Incubated
Systems
MCV MCV
before after
Case* incubation incubation Differencet
1 . 90-74 . 87-85 . -2-89
2 . 88-04 . 88-04 . 0-00
3 . 82-66 . 82-66 . 0-00
4 . 90-00 . 89-00 . -1-00
5 . 89-04 89-04 . 0-00
6 . 85-00 . 85-00 . 0-00
7 . 85-50 . 85-50 . 0-00
8 . 92-04 . 92-04 . 0-00
* The number of each case corresponds to the case with the same number in Table II.
t Mean of difference was -0-48;
Standard deviation was +0-85;
Standard Error was 0-32.
The level of significance (" T Test ") as related to the normal controls series was 1,2 (not
significant).
TABLE IV.-The Effect ofPlasma ofPatients with Malignant Tumours on the MCV
ofErythrocytes of Normal Persons in Incubated Systems
Histological Meta-
diagnosis stases
Squamouscarcinoma of . Absent
cervix
Squamouscarcinoma of
penis
Generalized carcinoma . Present
of peritoneum
Adenocarcinoma ofthe .
breast
. Ditto
. Ditto
. Granulosa cell carci-
noma of ovary
. Ditto
Serous papillary cysta- . Absent
denocarcinomaofthe
ovary
Adenocarcinoma of the . Present
ovary
. Mucoid carcinoma of
lung
Adenocarcinoma ofen- .
dometrium
Sarcoma ofthe uterus
. Adenocarcinoma of
colon
. Papillary transitional . Absent
cell carcinoma of
bladder
MCV
General before
con- incuba-
dition tion
Fair . 91-13
,, 86-68
Poor . P5-36
Fair . 93-00
Poor . 91-88
,, . 79-00
Fair . 86-21
,, 82-35
80-93
, 90-24
91-11
Poor . 97.43
,), .89-74
,, . 88-88
Fair . 86-00
Mean of difference was 7 29;
Standard error was 1-9 ;
Standard deviation was ±6 - 73.
The level of significance (" T Test ") as related to the normal controls serieswas4, 26 (significant.)
Case Age
1 . 55
2 42
3 43
4 . 37
5 . 50
6 . 48
7 . 39
8 . 60
9 . 37
10 . 60
11 66
12 . 49
13 . 44
14 . 56
15 . 77
MCV
after
incuba-
tion
. 113-30
101-48
. 97-56
109-41
97-88
84-00
93 75
. 87-25
. 80-93
90-24
97 77
101-33
5-00
88- 88
. 88-00
Absolute
difference
. +24-63
. +14-80
. +12-20
. +16-41
. +6-00
+5- 00
. +7-54
+4- 90
0-00
0-00
. +6-66
+3- 90
. +5-26
0-00
. +2-00VOLUME CHANGES OF ERYTHROCYTES
When the erythrocytes of patients with malignant disease were incubated
with normal plasma, no increase in MCV occurred (Table V).
TABLE V.-The Effect of Plasma of Control Persons on the Mean Corpuscular
Volume (MCV)ofErythrocytesofPatientswith Malignant TumoursinIncubated
Systems
MCV MCV
before after
Case* incubation incubation Differencet
1 . 93-02 . 91-08 . -1*94
2 . 9045 . 91*71 . 1-26
3 . 92-64 . 94 44 . 1-80
4 . 8948 . 85-01 -4-47
5 . 91*88 . 8865 . -3-23
6 . 100.00 96-66 . -3-34
7 . 9044 . 87*85 . -259
8 . 9354 . 91*93 . -1-61
9 . 8000 8000 . 000-
10 . 92-68 . 85-36 . -7-32
11 . 85-59 . 82-35 . -3-24
12 . 88-37 . 88-37 . 000
13 . 9444 . 9444 . 000
14 . 87-30 . 87-30 . 0-00
15 . 89-48 . 88-42 . -1-06
* The number of each case correspond to the case with the same number in Table IV.
t Mean of Difference was -1- 64;
Standard deviation was 2 -02;
Standard error was ±0- 7.
The level of significance (" T Test ") as related to the normal controls series was 1, 1 (not signi-
ficant.)
DISCUSSION
Increase in the volume of erythrocytes occurs as a first step in the course of
the haemolytic process. These prolytic changes in volume develop before complete
lysis with hypotonic solutions, saponin and lysolecithin.
The increase in volume of normal erythrocytes on incubation for one hour
withtheplasma ofpatientswithmalignantdisease, mayalsorepresent ahaemolytic
phenomenon and suggest that such plasma has increased haemolytic activity.
It has been shown that when normal blood is incubated for prolonged periods
of time (12 hours or more), the erythrocytes may undergo prolytic changes in
shape with increase in volume (Gillespie, 1943). These changes may be due to
the presence of the haemolysins demonstrated in the human plasma incubated
at 370 (Bergenhem and Fahraeus, 1936). Incubation is thought to release active
haemolysins from inactive complexes with inhibitors (Ponder, 1951). The
finding ofthe haemolytic substances in saline extracts of different tissues suggests
possible source of these autohaemolysins.
Furthermore, the haemolytic activity of extracts of malignant tumours is
muchgreaterthanthatofnormaltissues (Ponder andNesmith, 1952). Theincrease
in , glucuronidase and hyaluronidase content of the incubated extracts of malig-
nant tumours may be responsible for their increased haemolytic activity (Leroy
and Spurrier, 1955).
It is possible that the property of the plasma of patients with malignant
diseases described in this study, may be due to similar enzymatic activity. Our
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data appear to indicate that in the conditions we use, the effective concentration
of plasma lysins in patients with malignant tumours, is significantly higher than
in those with benign tumours or in healthy subjects.
Further work is carried out at present in order to investigate the hypothesis.
SUMMARY
The MCV of normal erythrocytes was significantly increased by incubation
with the plasma of 11 out of 15 patients with malignant tumours. The plasma
of normal subjects or of patients with benign tumours did not have this effect.
It is suggested that the erythrocytes enlargement is prolytic and due to increased
haemolytic activity of the plasma of patients with malignant neoplasms.
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